Nancy Jean Cox to Vaccines, Synthetic
This is a "connection" page, showing publications Nancy Jean Cox has written about Vaccines, Synthetic.
Connection Strength
0.130
-
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine. 1995; 13(15):1399-402.
Score: 0.032
-
Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model. Clin Vaccine Immunol. 2014 May; 21(5):722-31.
Score: 0.030
-
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J Infect Dis. 2011 Nov 15; 204(10):1491-9.
Score: 0.025
-
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses. 2009 Nov; 3(6):287-95.
Score: 0.022
-
Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus. Vaccine. 1988 Jun; 6(3):257-61.
Score: 0.020